Stocklytics Platform
APRE
Aprea Therapeutics
APRE
51
$4.24arrow_drop_up2.41%$0.10
Penny Stock

Performance History

Chart placeholder
Key Stats
Open$4.02
Prev. Close$4.01
EPS-3.28
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap21775184.00
PE Ratio-
LOWHIGH
Day Range4.02
4.32
52 Week Range2.78
8.84
Ratios
P/B Ratio0.83
Revenue-
Operating M. %-827.62%
Earnings$0.00
Earnings Growth %87.32%
EBITDA Margin %-
ROE %-43.83%
EPS-3.28

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$900.81
Perf. (24h)
arrow_drop_up1.20%$10.70
Market Cap$840.04B
Price$484.60
Perf. (24h)
arrow_drop_down1.09%-$5.38
Market Cap$451.00B
Price$147.14
Perf. (24h)
arrow_drop_down1.32%-$1.97
Market Cap$357.99B
Price$132.78
Perf. (24h)
arrow_drop_down0.13%-$0.18
Market Cap$331.08B

About Aprea Therapeutics (APRE)

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors, ovarian, breast, and prostate cancers. The company is also developing ATRN-1051, ATRN-354, and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Oren Gilad Ph.D.
Headquarters
Doylestown
Employees
9
Exchange
NASDAQ
add Aprea Therapeutics  to watchlist

Keep an eye on Aprea Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Aprea Therapeutics 's (APRE) price per share?

The current price per share for Aprea Therapeutics (APRE) is $4.24. The stock has seen a price change of $0.1 recently, indicating a 2.42% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Aprea Therapeutics (APRE)?

For Aprea Therapeutics (APRE), the 52-week high is $8.85, which is 108.66% from the current price. The 52-week low is $2.78, the current price is 52.52% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Aprea Therapeutics (APRE) a growth stock?

Aprea Therapeutics (APRE) has shown an average price growth of 0.41% over the past three years. It has received a score of 13 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Aprea Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Aprea Therapeutics (APRE) stock price performance year to date (YTD)?

As of the latest data, Aprea Therapeutics (APRE) has a year-to-date price change of -15.2%. Over the past month, the stock has experienced a price change of -19.98%. Over the last three months, the change has been -30.3%. Over the past six months, the figure is 16.16%.

help
Is Aprea Therapeutics (APRE) a profitable company?

Aprea Therapeutics (APRE) has a net income of -$14.29M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -827.62% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $576.18K. Operating income is noted at -$15.47M. Furthermore, the EBITDA is -$13.99M.

help
What is the market capitalization of Aprea Therapeutics (APRE)?

Aprea Therapeutics (APRE) has a market capitalization of $21.78M. The average daily trading volume is 16.16K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level